ADMP - Adamis Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Adamis Pharma's activity chart (see below) currently has 18 price targets and 19 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.17% with an average time for these price targets to be met of 943 days.

Most recent stock forecast was given by from D. BORAL CAPITAL on 19-May-2022.

Best performing analysts who are covering ADMP - Adamis Pharma:

Jason Kolbert Andrew D'silva Elliot Wilbur Jason Mccarthy Greg Chodaczek

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 22-Mar-2022

4 years 4 months 22 days ago
(19-May-2022)

4/4 (100%)

$-43.45 (-97.75%)

1702

Hold Since 16-Nov-2020

$1.5

5 years 10 months 25 days ago
(16-Nov-2020)

2/2 (100%)

$-38.7 (-96.27%)

1340

Hold Since 26-Nov-2019

6 years 10 months 15 days ago
(26-Nov-2019)

1/1 (100%)

$-364 (-98.11%)

2030

Sell Since 23-Jul-2019

$77

7 years 2 months 18 days ago
(23-Jul-2019)

2/6 (33.33%)

$-12.6 (-14.06%)

9

$5

$4.51 (920.41%)

9 years 9 months 21 days ago
(20-Dec-2016)

1/1 (100%)

$-191 (-97.45%)

2327

Show more analysts

Please expand the browser size to see the chart

What is ADMP (Adamis Pharma) average time for price targets to be met?

On average it took 943 days for the stock forecasts to be reached, with an average price target met ratio of 59.17%.

Which analyst most recently updated their price target on ADMP (Adamis Pharma)?

Which analyst has the current lower performing score on ADMP (Adamis Pharma) with a proven track record?

GREG CHODACZEK

Which analyst has the most public recommendations on ADMP (Adamis Pharma)?

has 0 price targets and 0 ratings on ADMP

Which analyst is the currently most bullish on ADMP (Adamis Pharma)?

Greg Chodaczek with the highest potential upside of $4.51

Which analyst is the currently most reserved on ADMP (Adamis Pharma)?

Elliot Wilbur with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?